Intradermal vaccination for Mycoplasma hyopneumoniae

Journal of Swine Health and Production

Volumn 13, Issue 1, 2005, Pages 19-27

  Jones, Gary F ^a,c   Rapp Gabrielson, Vicki ^a   Wilke, Rebecca ^a   Thacker, Eileen L ^b   Thacker, Brad J ^b   Gergen, Linda ^a   Sweeney, Diane ^a   Wasmoen, Terri ^a  

^a Intervet/Schering Plough Animal Health   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Intradermal vaccination; Mycoplasma hyopneumoniae; Swine

Indexed keywords

ANIMALIA; MYCOPLASMA; MYCOPLASMA HYOPNEUMONIAE; SUS SCROFA;

EID: 12444322092     PISSN: 1537209X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Halbur PG. Porcine respiratory diseases. Proc IPVS. Birmingham, UK. 1998:1-10.
2. Maes D, Deluyker H, Verdonck M, Castyck F, Miry C, Vrijens B, Verbeke W, Viaene J, de Kruif A. Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system. Vaccine. 1999;17:1024-1034.
3. Thacker EL, Thacker BJ, Boettcher TB, Jayappa H. Comparison of antibody production, lymphocyte stimulation, and protection induced by four commercial Mycoplasma hyopneumoniae bacterins. Swine Health Prod. 1998;6:107-112.
4. Otake S, Dee SA, Rossow KD, Moon RD, Pijoan C. Transmission of porcine reproductive and respiratory syndrome by needles. Vet Rec. 2002; 150:114-115.
5. Stier RF. The dirty dozen: Ways to reduce the 12 biggest foreign materials problems. Food Safety. 2003;9:44-50.
6. Schrijver RS, Langedijk JPM, Keil GM, Middel WGJ, Maris-Veldhuis M, Van Oirschot JT, Rijesewijk FAM. Comparison of DNA application methods to reduce BRSV shedding in cattle. Vaccine. 1998;16:130-134.
7. Dègano P, Sarphie DF, Banghams CRM. Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect® system. Vaccine. 1998;16:394-398.
8. Boettcher TB, Thacker BJ, Halbur PG, Waters WR, Nutsch R, Thacker EL. Vaccine efficacy and immune response to Mycoplasma hyopneumoniae challenge in pigs vaccinated against porcine reproductive and respiratory syndrome virus and M hyopneumoniae. Swine Health Prod. 2002;10:259-264.
9. Thacker EL, Thacker BJ, Kuhn M, Hawkins PA, Waters WR. Evaluation of local and systemic immune responses induced by intramuscular injection of Mycoplasma hyopneumoniae bacterin to pigs. Am J Vet Res. 2000;61:1384-1389.
10. Enioutina EY, Visic D, Daynes RA. The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity. Vaccine. 2000;18:2753-2767.
11. Bendelac A, Medzhitov R. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J Exp Med. 2002;195:19-23.
12. Cutler CW, Jotwani R, Pulendran B. Dendritic cells: immune saviors or Achilles' heel? Infect Immun. 2001;69:4703-4708.
13. th ed. Ames, Iowa: Iowa University Press; 1999:913-940.
14. Djordevic SP, Eamens GJ, Romalis LF, Nichols PJ, Taylor V, Chin J. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Aust Vet J. 1997;75:504-511.
15. Papazisi L, Silbart LK, Frasca S Jr, Rood D, Liao X, Gladd M, Javed MA, Geary SJ. A modified live Mycoplasma gallisepticum vaccine to protect chickens from respiratory disease. Vaccine. 2002;20:3709-3719.